Alphamab Oncology (HKSE:09966) Days Payable

: 62.90 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

Alphamab Oncology's average Accounts Payable for the six months ended in Jun. 2023 was HK$12.5 Mil. Alphamab Oncology's Cost of Goods Sold for the six months ended in Jun. 2023 was HK$36.3 Mil. Hence, Alphamab Oncology's Days Payable for the six months ended in Jun. 2023 was 62.90.

The historical rank and industry rank for Alphamab Oncology's Days Payable or its related term are showing as below:

HKSE:09966' s Days Payable Range Over the Past 10 Years
Min: 83.18 Med: 430.24 Max: 777.3
Current: 110.18

During the past 7 years, Alphamab Oncology's highest Days Payable was 777.30. The lowest was 83.18. And the median was 430.24.

HKSE:09966's Days Payable is ranked worse than
56.86% of 714 companies
in the Biotechnology industry
Industry Median: 151.205 vs HKSE:09966: 110.18

Alphamab Oncology's Days Payable declined from Jun. 2022 (148.32) to Jun. 2023 (62.90). It may suggest that Alphamab Oncology accelerated paying its suppliers.

Alphamab Oncology Days Payable Historical Data

The historical data trend for Alphamab Oncology's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

777.30

83.18

115.42

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial								531.04	148.32	63.21	62.90	174.68

Competitive Comparison

For the Biotechnology subindustry, Alphamab Oncology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphamab Oncology Days Payable Distribution

For the Biotechnology industry and Healthcare sector, Alphamab Oncology's Days Payable distribution charts can be found below:

* The bar in red indicates where Alphamab Oncology's Days Payable falls into.

Alphamab Oncology Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Alphamab Oncology's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (14.001	+	8.5)	/	2 )	/	49.366	*	365
=	11.2505					/	49.366	*	365
=	83.18

Alphamab Oncology's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (8.5	+	16.504)	/	2 )	/	36.275	*	365 / 2
=	12.502					/	36.275	*	365 / 2
=	62.90

Alphamab Oncology Days Payable Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology (HKSE:09966) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

3NK:Germany

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024

Website

https://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines